Bio-techs across Australia have done nothing on this US rally. Its a shame. There are less worthy stocks trading in the US with market caps ten times the likes of PAR. Its a crying shame and a test of patience to be on a few Aussie bio-tech stocks with such amazing products but just no traction in the investment community who will pay 1,000 P/E for some over hyped crap but ignore paradigm changers.
Ann: Paradigm doses first participant in Synovial Fluid Trial, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $76.98M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.5¢ | 21.0¢ | $242.2K | 1.102M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16020 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 310000 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |